These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2696390)

  • 41. [New technologies in the prevention, detection, diagnosis and treatment of tuberculosis in children].
    Mitinskaia LA
    Probl Tuberk; 2003; (1):19-24; discussion 24-5. PubMed ID: 12652978
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Compliance, tolerance and effectiveness of a short chemoprophylaxis regimen for the treatment of tuberculosis].
    Martínez Alfaro E; Solera J; Serna E; Cuenca D; Castillejos ML; Espinosa A; Sáez L
    Med Clin (Barc); 1998 Oct; 111(11):401-4. PubMed ID: 9834911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
    Tam CM; Chan SL; Kam KM; Goodall RL; Mitchison DA
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood--a pilot project].
    Magdorf K; Arizzi-Rusche AF; Geiter LJ; O'Brien RJ; Wahn U
    Pneumologie; 1994 Oct; 48(10):761-4. PubMed ID: 7808991
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Operational evaluation of treatment for tuberculosis. Results of 8- and 12-month regimens in Peru.
    Hopewell PC; Ganter B; Baron RB; Sanchez-Hernandez M
    Am Rev Respir Dis; 1985 Oct; 132(4):737-41. PubMed ID: 3901842
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-tuberculosis programs in Thailand: a cost analysis.
    Chunhaswasdikul B; Kamolratanakul P; Jittinandana A; Tangcharoensathien V; Kuptawintu S; Pantumabamrung P
    Southeast Asian J Trop Med Public Health; 1992 Jun; 23(2):195-9. PubMed ID: 1439970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Tuberculosis therapy 1990].
    Villiger B
    Schweiz Rundsch Med Prax; 1990 May; 79(21):670-4. PubMed ID: 2190295
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effectiveness of short-course, intermittent chemotherapy for tuberculosis in young infants aged less than 6 months.
    Kiper N; Göçmen A; Dilber E; Ozçelik U
    Clin Pediatr (Phila); 1998 Jul; 37(7):433-6. PubMed ID: 9675437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short-course intensive treatment of patients with destructive pulmonary tuberculosis.
    Bondarev IM
    Scand J Respir Dis Suppl; 1978; 102():53-5. PubMed ID: 278216
    [No Abstract]   [Full Text] [Related]  

  • 50. [Respiratory tuberculosis in Seine-Saint-Denis. Results of treatment].
    Lepetit C; Thebaud-Mony A
    Rev Mal Respir; 1989; 6(5):451-6. PubMed ID: 2602618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short course treatment with two drugs, isoniazid plus rifampicin for six months: a controlled clinical trial with two treatment regimens.
    Dubra FA
    Bull Int Union Tuberc; 1976; 51(1):61-4. PubMed ID: 1030314
    [No Abstract]   [Full Text] [Related]  

  • 52. Clinical research in the treatment of tuberculosis: current status and future prospects.
    Chang KC; Yew WW; Sotgiu G
    Int J Tuberc Lung Dis; 2015 Dec; 19(12):1417-27. PubMed ID: 26614181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effectiveness and tolerance of antituberculosis treatment regimens without isoniazid and rifampicin: analysis of 85 cases].
    Tost JR; Vidal R; Maldonado J; Caylà JA
    Arch Bronconeumol; 2008 Sep; 44(9):478-83. PubMed ID: 19000510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [An experimental study of the chemotherapeutic efficacy of flurenizid, a new antitubercular pharmaceutical].
    Khomenko AG; Golyshevskaia VI; Maslova LI; Kalmykova GN; Uvarova OA
    Probl Tuberk; 1990; (6):3-7. PubMed ID: 2217100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Current chemotherapy of pulmonary tuberculosis].
    Medici TC; Steiner A
    Schweiz Med Wochenschr; 1979 Feb; 109(6):190-9. PubMed ID: 424721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness analysis of three short-course anti-tuberculosis programmes compared with a standard regimen in Thailand.
    Kamolratanakul P; Chunhaswasdikul B; Jittinandana A; Tangcharoensathien V; Udomrati N; Akksilp S
    J Clin Epidemiol; 1993 Jul; 46(7):631-6. PubMed ID: 8326348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Late results of 12-month-long hospital treatment of chronic pulmonary tuberculosis with rifampicin combined with other antitubercular agents].
    Danilczuk R; Piekarniak K; Wyczólkowski M; Martyniak K
    Pneumonol Pol; 1977 Feb; 45(2):125-30. PubMed ID: 840724
    [No Abstract]   [Full Text] [Related]  

  • 58. Unfinished battle with childhood tuberculosis: is it curable with less drugs and shorter duration?
    Cinel G; Kiper N; Pekcan S; Koyun M; Köse M; Çobanoğlu N; Tana Aslan A; Yalçın E; Doğru D; Özçelik U; Göçmen A
    Tuberk Toraks; 2013; 61(4):320-6. PubMed ID: 24506748
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparative evaluation of drug combinations used in the treatment of pulmonary tuberculosis.
    Miller SD
    S Afr Med J; 1983 May; 63(20):764-6. PubMed ID: 6845095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [New methods of prevention, diagnosis and treatment of tuberculosis in children].
    Mitinskaia LA; Elufimova VF; Gol'tsova NA; Pogodaeva NP; Gnezdilova TM; Iavorskiĭ KM; Kotova LI; Ergeshov AE; Iukhimenko NV; Matsulevich TV
    Probl Tuberk; 1991; (11):9-12. PubMed ID: 1775471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.